LB Pharmaceuticals Inc (LBRX) - Latest Market Data

Price & Market Data

Price: $31.13

Daily Change: -$1.57 / 5.03%

Daily Range: $30.84 - $32.60

Market Cap: $892,672,512

Daily Volume: 77,804

Performance Metrics

1 Week: -5.32%

1 Month: 22.41%

3 Months: 28.53%

6 Months: 102.8%

1 Year: 63.84%

YTD: 39.85%

About LB Pharmaceuticals Inc (LBRX)

Access real-time market insights for LB Pharmaceuticals Inc (LBRX). The stock is trading at 31.13, reflecting a daily change of -$1.57 / 5.03%. With a market capitalization of 892,672,512, it showcases performance metrics including 6-month (102.8%) and 1-month (22.41%) returns.

Company Details

Employees: 27

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.

Selected stocks

Paycom Software, Inc. (PAYC)

Chewy, Inc. (CHWY)

EZGO Technologies Ltd. (EZGO)

Bold Eagle Acquisition Corp. (BEAG)